These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


467 related items for PubMed ID: 12360109

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.
    Mikus G, Schöwel V, Drzewinska M, Rengelshausen J, Ding R, Riedel KD, Burhenne J, Weiss J, Thomsen T, Haefeli WE.
    Clin Pharmacol Ther; 2006 Aug; 80(2):126-35. PubMed ID: 16890574
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Fatal doxepin intoxication--suicide or slow gradual intoxication?
    Neukamm MA, Vogt S, Hermanns-Clausen M, Naue J, Thierauf A, Auwärter V.
    Forensic Sci Int; 2013 Apr 10; 227(1-3):82-4. PubMed ID: 22999230
    [Abstract] [Full Text] [Related]

  • 26. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
    Aynacioglu AS, Sachse C, Bozkurt A, Kortunay S, Nacak M, Schröder T, Kayaalp SO, Roots I, Brockmöller J.
    Clin Pharmacol Ther; 1999 Aug 10; 66(2):185-92. PubMed ID: 10460072
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients.
    Dandara C, Masimirembwa CM, Magimba A, Sayi J, Kaaya S, Sommers DK, Snyman JR, Hasler JA.
    Eur J Clin Pharmacol; 2001 Apr 10; 57(1):11-7. PubMed ID: 11372584
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response.
    Yadav SS, Ruwali M, Pant MC, Shukla P, Singh RL, Parmar D.
    Mutat Res; 2010 Feb 03; 684(1-2):49-55. PubMed ID: 19954746
    [Abstract] [Full Text] [Related]

  • 34. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
    Chainuvati S, Nafziger AN, Leeder JS, Gaedigk A, Kearns GL, Sellers E, Zhang Y, Kashuba AD, Rowland E, Bertino JS.
    Clin Pharmacol Ther; 2003 Nov 03; 74(5):437-47. PubMed ID: 14586384
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype.
    Jan MW, ZumBrunnen TL, Kazmi YR, VanDenBerg CM, Desai HD, Weidler DJ, Flockhart DA.
    Drug Metabol Drug Interact; 2002 Nov 03; 19(1):1-11. PubMed ID: 12222750
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese.
    He L, Chen S, Li J, Xie X, Huang L, Kuang Y, Xu K, Huang W, Zhao Y, Yang G, Guo C.
    Clin Exp Pharmacol Physiol; 2020 Oct 03; 47(10):1659-1663. PubMed ID: 32469422
    [Abstract] [Full Text] [Related]

  • 38. Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans.
    Shon JH, Yoon YR, Kim KA, Lim YC, Lee KJ, Park JY, Cha IJ, Flockhart DA, Shin JG.
    Pharmacogenetics; 2002 Mar 03; 12(2):111-9. PubMed ID: 11875365
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.